We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+10.66%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$239M
AUM Growth
+$41.4M
Cap. Flow
+$18M
Cap. Flow %
7.51%
Top 10 Hldgs %
39.46%
Holding
44
New
11
Increased
12
Reduced
7
Closed
5

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$6.14M
2
ABT icon
Abbott
ABT
+$5.25M
3
SNN icon
Smith & Nephew
SNN
+$4.71M
4
INSP icon
Inspire Medical Systems
INSP
+$4.46M
5
DVA icon
DaVita
DVA
+$4.16M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$4.72M
2
AVTR icon
Avantor
AVTR
+$3.79M
3
CTLT
CATALENT, INC.
CTLT
+$3.64M
4
IQV icon
IQVIA
IQV
+$3.44M
5
COR icon
Cencora
COR
+$2.93M

Sector Composition

Rank Sector Weight
1 Healthcare 94.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$12.1M 5.06%
135,588
+35,588
+36% +$2.64M
THC icon
2
Tenet Healthcare
THC
$21.1B
$11M 4.58%
145,000
+5,000
+4% +$317K
HCA icon
3
HCA Healthcare
HCA
$89.5B
$10.8M 4.52%
40,000
– –
UHS icon
4
Universal Health Services
UHS
$10.5B
$10.3M 4.3%
67,500
+2,500
+4% +$336K
NVO
5
Novo Nordisk
NVO
$209B
$9.31M 3.89%
90,000
– –
BSX icon
6
Boston Scientific
BSX
$71.5B
$9.25M 3.86%
160,000
– –
LLY icon
7
Eli Lilly
LLY
$1.06T
$8.74M 3.65%
15,000
– –
SYK icon
8
Stryker
SYK
$130B
$8.38M 3.5%
28,000
+500
+2% +$140K
ISRG icon
9
Intuitive Surgical
ISRG
$134B
$7.59M 3.17%
22,500
– –
ACHC icon
10
Acadia Healthcare
ACHC
$2.94B
$7M 2.92%
90,000
+15,000
+20% +$1.11M
MCK icon
11
McKesson
MCK
$101B
$6.95M 2.9%
15,000
-2,500
-14% -$1.14M
HUM icon
12
Humana
HUM
$46.2B
$6.87M 2.87%
15,000
-2,500
-14% -$1.23M
MDT icon
13
Medtronic
MDT
$112B
$6.59M 2.75%
80,000
– –
BIIB icon
14
Biogen
BIIB
$30.7B
$6.47M 2.7%
+25,000
New +$6.14M
SGRY icon
15
Surgery Partners
SGRY
$2.03B
$6.4M 2.67%
200,000
+25,000
+14% +$725K
TMO icon
16
Thermo Fisher Scientific
TMO
$220B
$6.37M 2.66%
12,000
+1,500
+14% +$726K
DXCM icon
17
DexCom
DXCM
$32B
$6.21M 2.59%
50,000
– –
ZBH icon
18
Zimmer Biomet
ZBH
$18.4B
$6.08M 2.54%
50,000
– –
EHC icon
19
Encompass Health
EHC
$12.4B
$6M 2.51%
90,000
– –
SEM
20
DELISTED
Select Medical
SEM
$5.88M 2.45%
464,000
+107,011
+30% +$1.35M
DHR icon
21
Danaher
DHR
$144B
$5.78M 2.42%
25,000
-6,020
-19% -$1.28M
ABT icon
22
Abbott
ABT
$187B
$5.78M 2.41%
+52,500
New +$5.25M
PODD icon
23
Insulet
PODD
$9.79B
$5.75M 2.4%
26,500
+6,500
+33% +$1.11M
INSP icon
24
Inspire Medical Systems
INSP
$1.74B
$5.59M 2.34%
+27,500
New +$4.46M
BMRN icon
25
BioMarin Pharmaceuticals
BMRN
$12.4B
$5.3M 2.22%
55,000
+5,000
+10% +$442K
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q4 2023 Portfolio in Review

As of Q4 2023, Sivik Global Healthcare held 44 positions worth $239M, up 21% from $198M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Sivik Global Healthcare deployed $18M of net new capital in Q4 2023, opening 11 new positions and adding to 12 existing holdings. Its largest new stake was Biogen: 25,000 shares worth $6.47M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 96% a quarter earlier.

On the sell side, the largest reduction was Cencora, an estimated $2.93M trimmed.

  • Sivik Global Healthcare's largest Q4 2023 buy was Biogen: 25,000 shares worth $6.47M.
  • Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q4 2023, an estimated $2.64M increase.
  • Sivik Global Healthcare's biggest Q4 2023 reduction was Cencora, cutting an estimated $2.93M.
  • Sivik Global Healthcare fully exited Baxter International in Q4 2023, selling an estimated $4.72M.
  • Sivik Global Healthcare's ten largest holdings make up 39% of its $239M portfolio in Q4 2023.
  • Sivik Global Healthcare opened 11 new positions and closed 5 in Q4 2023.
  • Sivik Global Healthcare's portfolio value rose 21% quarter-over-quarter to $239M.

Based on Sivik Global Healthcare's 13F filing for Q4 2023, filed 5 Feb 2024.